ArticleIndian dermatology online journal2025
Comparison of Dermoscopy and Wood's Lamp in the Assessment of Stability of Vitiligo.
Article in Indian dermatology online journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Border Sharpness Index: A Proof-of-Concept Approach for Quantifying Pigmentary Transition Morphology in Vitiligo.Cureus · 2026Article
- Technological advances in vitiligo management: perspectives on AI, mobile tools, and clinical utility.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe stability of vitiligo is mainly assessed using clinical criteria. Wood's lamp and dermoscopy have been proposed as valuable alternatives.
objectiveThe objective of the study was to compare the utility of dermoscopy and Wood's lamp examination in the assessment of stability in vitiligo compared with clinical criteria and to define the best cutoff score using BPLeFoSK criteria in determining vitiligo stability. PATIENTS AND
methodsThe study was conducted among patients with vitiligo attending a tertiary care center. The study design was a diagnostic test evaluation. One hundred and ten patients with vitiligo were recruited over 18 months. The most recent lesion in each patient was assessed for its stability using the clinical evaluation, Vitiligo Disease Activity (VIDA) score, Wood's lamp, and dermoscopy with the BPLeFoSK score, where a score ≥1.5 indicated stable vitiligo.
resultsThe study revealed moderate agreement between Wood's lamp and dermoscopy (κ=0.55) and a fair agreement between clinical evaluation and both Wood's lamp (κ=0.33) and dermoscopy (κ=0.40). Wood's lamp showed 72.3% sensitivity and 66.7% specificity, while dermoscopy had 74.1% sensitivity and 73.5% specificity. Wood's lamp had 87% accuracy in identifying stable vitiligo but only 43.9% accuracy in ruling it out compared to clinical criteria. Dermoscopy demonstrated slightly higher effectiveness. The area under the receiver operating characteristic curve for dermoscopy versus clinical criteria was 0.826, while Wood's lamp scored 0.695. A BPLeFoSK cutoff score of ≥3.5 was specific (97.6%) for identifying stable vitiligo, but sensitivity was low (25.6%). LIMITATIONS: The study's limitations included the cross-sectional study design, examination of only one lesion per patient, lack of blinding, absence of follow-up, absence of histopathologic examination of the lesions, lack of sequential observation through a combination of clinical, dermoscopic, or Wood's lamp examination, and utilization of VIDA scoring system which itself has recall bias. Use of a non-validated scoring system (BPLeFoSK) is also a limitation of this study.
conclusionThis study shows that dermoscopy and Wood's lamp are equally helpful in clinical assessment. We propose a cutoff score of more than or equal to 3.5 in BPLeFoSK score.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.